Health experts in the UK have begun using a drug developed to treat cancer in Norway as one of the first six promising drugs to treat the corona virus. This treatment is called Beam Sentinel.
In this regard, it is hoped that this medicine will be given to 120 patients undergoing treatment in six hospitals of the National Health Trust of the United Kingdom on a trial basis from this week.
In laboratory analysis at the University of Iowa, the drug, which is in the form of a pill, will enter the human body to boost the immune system and make the AXL receptors ineffective so that the virus does not enter the lungs and increase its numbers. Coins
The drug's manufacturer, Bergen Bio, says that the drug has shown good and promising results in trials on cancer patients, and that the main thing is that it is taken once a day and its side or side effects. There are also very few. The biotech firm, based in the western coastal region of Bergen, Norway, says the drug is suitable for the elderly and frail people who suffer from severe illnesses. The Accord program has been selected to treat the corona virus.
A British health official told a British newspaper that the other two drugs included Medi3506 and Ecala Bruti Nib. But he did not name the other three drugs.
Medi 3506 is found in Fergusga, which is very helpful in the treatment of chronic obstructive pulmonary disease (COPD) and diabetic kidney disease.
Calcaneus, whose generic name is Ekala Bruti Nib, is used to treat cancer. More than 76,000 patients recover from Corona, Iran
More than 76,000 patients recover from Corona, Iran
Beam Sentinab will be given to patients in the second trial phase from this week and it is hoped that the results will be known in a few months.
"We are pleased with the pilot phase that has been launched in partnership with the government, scientists and industry, and are hopeful that this will soon be part of a global effort," said Richard Godfrey, CEO of Bergen Bio. Success will come. British Health Minister Matt Hancock also called the experience promising.
Post a Comment